跳至主要内容
临床试验/IRCT201105186515N1
IRCT201105186515N1已完成2 期

Evaluation of effectiveness and safety of Magnesium Carbonate and comparison with calcium carbonate in hyperphosphatemic end stage renal disease patients on chronic hemodialysis.

Vice chancellor for research, Isfahan University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 90 years(—)
性别
All

入选标准

  • age>18 years; serum phosphorus >5.5 mg/dl; at least 3 months on hemodialysis.
  • exclusion criteria: serum magnesium > 4 mg/dl; pregnancy; previous parathyroidectomy; sever hyperparathyroidism(iPTH> 500 pg/ml); Medical disease cause diarrhea; Kidney transplant; Patient Death; Non-compliance of drug usage (at least 80% of prescribed drug must be used); Drug complications making the patient unable to continue the treatment; Lost hemodialysis more than one per month or Irregular hemodialysis

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Isfahan University of Medical Sciences

相似试验